Evidence map›Paper›PMID 40423303›Full record

ArticleToxins2025

Is There a Correlation Between Masticatory Muscle Thickness and Pain After Botulinum Toxin Injections in Myogenic TMD Patients?: A Pilot Study.

Hye-Ji Park, Hee-Jin Kim, Sung Ok Hong

Abstract read
In one paragraph

Article in Toxins, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Hye-Ji ParkDepartment of Oral Medicine, Kyung Hee University Hospital at Gangdong, Seoul 05278, Republic of Korea.ORCID 0000-0002-6918-1562
Hee-Jin KimDivision in Anatomy and Developmental Biology, Department of Oral Biology, Human Identification Research Institute, BK21 FOUR Project, Yonsei University College of Dentistry, Seoul 03722, Republic of Korea.ORCID 0000-0002-1139-6261
Sung Ok HongDepartment of Oral and Maxillofacial Surgery, Kyung Hee University Hospital at Gangdong, Seoul 05278, Republic of Korea.ORCID 0000-0001-9975-8177

Funding

National Research Foundation of Korea 2021R1F1A1049784
6 · The paper itself

Abstract

Botulinum toxin type A (BoNT-A), a potent neurotoxin, is increasingly used to treat myogenic temporomandibular disorders (TMDs); however, the interplay between muscle atrophy and pain relief remains incompletely understood. This pilot study investigated how masseter and temporalis muscle thickness and pain intensity change over 12 weeks following BoNT-A injections in 15 patients (mean age 51.42 years) with myogenic TMD. Muscle thickness was measured via ultrasonography across multiple anatomical positions under both clenching and resting conditions at baseline and at 2, 4, 8, and 12 weeks post-injection. Significant thinning of both muscles occurred within 2 weeks, lasting until 12 weeks, but became less pronounced after the first month. Pain intensity showed parallel decreases, most notably early on, but these reductions were not consistently statistically significant. Correlation analyses revealed no strong persistent association between muscle thickness and pain except for a moderately positive correlation in the anterior temporalis at two weeks (r = 0.61,

Indexed as

Botulinum Toxins, Type AMasseter MuscleMasticatory MusclesNeuromuscular AgentsTemporomandibular Joint DisordersAdultAgedFemaleHumansInjections, IntramuscularMaleMiddle AgedPain MeasurementPilot ProjectsTemporal MuscleUltrasonographyBotulinum Toxins, Type ANeuromuscular Agentsbotulinum toxinmasseter musclemuscle thicknessmyofascial paintemporalis muscletemporomandibular disorderultrasonography

Identifiers

PMID40423303
PMCPMC12116159

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.